Mark S Schroeder Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark S Schroeder.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark S Schroeder. Mark S Schroeder is EVP, President-Diagnostics Lab in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Latest Insider Trading Transactions of Mark S Schroeder
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 251.88 | 667 | 168,004 | 5,006 | 5.7 K to 5 K (-11.76 %) |
Mar 30 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 251.58 | 1,079 | 271,455 | 5,673 | 6.8 K to 5.7 K (-15.98 %) |
Mar 30 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Grant | A | 0.00 | 2,413 | 0 | 6,752 | 4.3 K to 6.8 K (+55.61 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 283 | 0 | 6,754 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 234 | 0 | 7,037 | |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 237.06 | 85 | 20,150 | 4,339 | 4.4 K to 4.3 K (-1.92 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 237.06 | 103 | 24,417 | 4,424 | 4.5 K to 4.4 K (-2.28 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 238.26 | 78 | 18,584 | 4,527 | 4.6 K to 4.5 K (-1.69 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 283 | 0 | 4,605 | 4.3 K to 4.6 K (+6.55 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 238.26 | 64 | 15,249 | 4,322 | 4.4 K to 4.3 K (-1.46 %) |
Feb 17 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 234 | 0 | 4,386 | 4.2 K to 4.4 K (+5.64 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 560 | 0 | 7,271 | |
Feb 08 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 225.85 | 203 | 45,848 | 4,152 | 4.4 K to 4.2 K (-4.66 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 223.78 | 154 | 34,462 | 4,355 | 4.5 K to 4.4 K (-3.42 %) |
Feb 08 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 560 | 0 | 4,509 | 3.9 K to 4.5 K (+14.18 %) |
Feb 04 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 233.39 | 4,600 | 1,073,594 | 4,600 | |
Feb 04 2021 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 0.00 | 1,330 | 0 | 7,831 | |
Nov 09 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 2,010 | 0 | 6,501 | |
Nov 09 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 214.42 | 835 | 179,041 | 4,537 | 5.4 K to 4.5 K (-15.54 %) |
Nov 09 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 2,010 | 0 | 5,372 | 3.4 K to 5.4 K (+59.79 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 131.95 | 1,153 | 152,138 | 3,213 | 4.4 K to 3.2 K (-26.41 %) |
Apr 01 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Grant | A | 0.00 | 3,880 | 0 | 4,366 | 486 to 4.4 K (+798.35 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 283 | 0 | 8,511 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 233 | 0 | 8,794 | |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 188.49 | 103 | 19,414 | 486 | 589 to 486 (-17.49 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 188.49 | 85 | 16,022 | 589 | 674 to 589 (-12.61 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 187.51 | 78 | 14,626 | 674 | 752 to 674 (-10.37 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 283 | 0 | 752 | 469 to 752 (+60.34 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 187.51 | 64 | 12,001 | 469 | 533 to 469 (-12.01 %) |
Feb 14 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 233 | 0 | 533 | 300 to 533 (+77.67 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | M | 0.00 | 297 | 0 | 9,027 | |
Feb 11 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Sell | S | 181.99 | 108 | 19,655 | 300 | 408 to 300 (-26.47 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Payment of Exercise | F | 182.33 | 82 | 14,951 | 408 | 490 to 408 (-16.73 %) |
Feb 11 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Buy | M | 0.00 | 297 | 0 | 490 | 193 to 490 (+153.89 %) |
Feb 06 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 182.51 | 7,300 | 1,332,323 | 7,300 | |
Feb 06 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 0.00 | 1,680 | 0 | 9,324 | |
Nov 07 2019 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 0.00 | 6,030 | 0 | 7,644 |
Page: 1